Accessibility Menu
Organigram Global Stock Quote

Organigram Global (NASDAQ: OGI)

$1.76
(1.1%)
+0.02
Price as of December 24, 2025, 1:00 p.m. ET

KEY DATA POINTS

Current Price
$1.76
Daily Change
(1.1%) +$0.02
Day's Range
$1.72 - $1.78
Previous Close
$1.76
Open
$1.74
Beta
1.54
Volume
527,803
Average Volume
989,604
Market Cap
$238M
Market Cap / Employee
$1.76M
52wk Range
$0.85 - $2.24
Revenue
N/A
Gross Margin
0.04%
Dividend Yield
N/A
EPS
-$0.16
CAPs Rating
N/A
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Organigram Global Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
OGI+12.82%-69.01%-20.88%-80%
S&P+14.77%+87.2%+13.35%+247%
Advertisement

Organigram Global Company Info

Based in Atlantic Canada, OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.

News & Analysis

The Fool has written over 300 articles on Organigram Global.

Financial Health

General

Q3 2025YOY Change
Revenue$58.13M77.4%
Gross Profit$302.04K116.2%
Gross Margin0.52%6.2%
Market Cap$272.68M38.8%
Market Cap / Employee$239.40K0.0%
Employees1.1K26.8%
Net Income-$27,563.73K-592.0%
EBITDA-$16,762.30K-48.1%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$60.08M-38.8%
Accounts Receivable$45.70M89.1%
Inventory89.145.8%

Liabilities

Q3 2025YOY Change
Long Term Debt$5.57M123.3%
Short Term Debt$721.58K-10.2%

Ratios

Q3 2025YOY Change
Return On Assets-5.37%7.5%
Return On Invested Capital-31.97%4.5%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$479.84K-108.1%
Operating Free Cash Flow-$973.08K-113.4%

Valuation

MetricQ1 2025Q2 2025YoY Change
Price to Earnings15.0294.96-
Price to Book0.770.570.670.9610.82%
Price to Sales1.500.981.131.47-12.61%
Price to Tangible Book Value0.790.760.911.3146.77%
Price to Free Cash Flow TTM101.02-
Enterprise Value to EBITDA-12.03-7.84-11.10-12.9844.72%
Free Cash Flow Yield1.0%-
Return on Equity-18.3%4.8%1.9%-7.9%-49.49%
Total Debt$6.91M$6.63M$6.70M$6.29M90.74%

No results found

No podcast episodes available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.